ambr, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

ambr, Inc. - overview

Established

2018

Location

Tokyo, Tokyo, Japan

Primary Industry

Software

About

Ambr, Inc. is a Japan-based company specializing in software solutions for the biotechnology and pharmaceutical industries, focusing on streamlining bioprocessing and enhancing productivity in drug development. Founded in 2018 in Tokyo, Japan, ambr, Inc. provides software solutions in the biotechnology sector, primarily focusing on bioprocessing systems.


The company has engaged in four deals to date, with its most recent funding round being a Series A, raising JPY 1. 02 billion on July 5, 2022, from investors including ANRI, DENTSU GROUP INC. , INTAGE Inc. , SBI Investment, and Tokyu Fudosan Holdings.


The CEO is Bill Hullinger, who has a history of leadership in the tech sector. Ambr, Inc. specializes in developing advanced solutions for the biotechnology and pharmaceutical sectors. Their core offerings include innovative bioprocessing platforms and systems that optimize cell culture processes, enhancing productivity and efficiency in drug development.


The company serves a diverse client base, including research institutions, biotechnology firms, and pharmaceutical companies globally, particularly in North America, Europe, and parts of Asia, addressing critical biomanufacturing challenges such as scaling production and ensuring quality. Ambr, Inc. follows a structured revenue model comprising both direct sales and subscription services for its bioprocessing platforms. Revenue is generated from the sale of equipment and consumables, along with service contracts for maintenance and software updates.


Clients typically invest in comprehensive packages, which include the bioprocessing systems and recurring subscriptions for proprietary software tools that facilitate data analysis and process optimization, ensuring long-term customer relationships and consistent revenue streams. In July 2022, ambr, Inc. raised JPY 1. 02 billion through Series A funding to support the development of a metaverse platform.


The company is expected to utilize these funds to enhance its product offerings and explore new market opportunities. Future plans include expanding into additional geographical regions, with a focus on North America and Europe, aiming to launch new products that integrate advanced technologies within the next two years.


Current Investors

ANRI, ModelingCafe Inc., Japan Finance Corporation

Primary Industry

Software

Sub Industries

Gaming, Multimedia & Graphics

Website

www.ambr.co.jp

Verticals

Virtual Reality (VR)

Company Stage

Series A

Total Amount Raised

Subscriber access only

ambr, Inc. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.